- Home
- CVM vs DTF Comparison
CVM vs DTF Comparison
Compare CVM & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- DTF
- Stock Information
- Founded
- CVM 1983
- DTF 1991
- Country
- CVM United States
- DTF United States
- Employees
- CVM N/A
- DTF N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- DTF Investment Managers
- Sector
- CVM Health Care
- DTF Finance
- Exchange
- CVM Nasdaq
- DTF Nasdaq
- Market Cap
- CVM 71.2M
- DTF 79.8M
- IPO Year
- CVM 1987
- DTF N/A
- Fundamental
- Price
- CVM $9.91
- DTF $11.38
- Analyst Decision
- CVM
- DTF
- Analyst Count
- CVM 0
- DTF 0
- Target Price
- CVM N/A
- DTF N/A
- AVG Volume (30 Days)
- CVM 294.7K
- DTF 21.1K
- Earning Date
- CVM 08-14-2025
- DTF 01-01-0001
- Dividend Yield
- CVM N/A
- DTF 3.64%
- EPS Growth
- CVM N/A
- DTF N/A
- EPS
- CVM N/A
- DTF 0.44
- Revenue
- CVM N/A
- DTF N/A
- Revenue This Year
- CVM N/A
- DTF N/A
- Revenue Next Year
- CVM N/A
- DTF N/A
- P/E Ratio
- CVM N/A
- DTF $24.34
- Revenue Growth
- CVM N/A
- DTF N/A
- 52 Week Low
- CVM $1.98
- DTF $10.29
- 52 Week High
- CVM $38.70
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- CVM 51.86
- DTF 61.47
- Support Level
- CVM N/A
- DTF $11.32
- Resistance Level
- CVM $10.48
- DTF $11.42
- Average True Range (ATR)
- CVM 1.11
- DTF 0.07
- MACD
- CVM -0.64
- DTF 0.00
- Stochastic Oscillator
- CVM 73.74
- DTF 80.95
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.